Simon Dujardin, PhD

Citée par

	Toutes	Depuis 2019
Citations	4664	4112
indice h	23	21
indice i10	27	27

960

480

240

720

201220132014201520162017201820192020202120222023202420 35 33 67 74 95 209 413 641 859 926 960 308

Accès public

Tout afficher

30 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Bradley HymanMassachusetts General Hospital, Harvard Medical SchoolAdresse e-mail validée de partners.org
Luc BueeUniversité de LilleAdresse e-mail validée de univ-lille.fr
Tarun KamathMD-PhD Student at Harvard Medical SchoolAdresse e-mail validée de hms.harvard.edu
Rachel BennettAssistant Professor of Neurology, Massachusetts General Hospital, Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu
Matthew P. FroschMassachusetts General Hospital & Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu
Naomi KlicksteinGraduate Student, Columbia UniversityAdresse e-mail validée de columbia.edu
George CarlsonUniversity of California, San Francisco; McLaughlin Research InstituteAdresse e-mail validée de ucsf.edu
Susanne WegmannGroup Leader at DZNE BerlinAdresse e-mail validée de berlin.de
Nicole DéglonLausanne University Hospital (CHUV)Adresse e-mail validée de chuv.ch
Joris WinderickxKU LeuvenAdresse e-mail validée de bio.kuleuven.be
Pieter BeerepootFog PharmaAdresse e-mail validée de fogpharma.com
Judith A. Jebanathirajah SteenAssociate Professor of Neurology, Harvard Medical SchoolAdresse e-mail validée de childrens.harvard.edu
Mukesh KumarPrincipal Scientist, Cell Signaling TechnologyAdresse e-mail validée de cellsignal.com
J. Paul TaylorSt. Jude Children's Research HospitalAdresse e-mail validée de stjude.org
Amayra Hernández-VegaInstitute for Bioengineering of Catalonia (IBEC)Adresse e-mail validée de ibecbarcelona.eu
Bahareh EftekharzadehNereidTxAdresse e-mail validée de Nereidtx.com
AA HymanMax Planck institute of molecular cell biology and geneticsAdresse e-mail validée de mpi-cbg.de
Daniel J MullerETH Zurich, Department of Biosystems Science and EngineeringAdresse e-mail validée de bsse.ethz.ch
jarek maciejewskiAdresse e-mail validée de ccf.org
Sarah DeVosDirector & Principal Scientist, Denali TherapeuticsAdresse e-mail validée de dnli.com

Suivre

Simon Dujardin, PhD

Instructor in Neurology, Massachusetts General Hospital, Harvard Medical School

Adresse e-mail validée de mgh.harvard.edu - Page d'accueil

Tauopathies Alzheimer's disease neurosciences


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Tau protein liquid–liquid phase separation can initiate tau aggregation S Wegmann, B Eftekharzadeh, K Tepper, KM Zoltowska, RE Bennett, ... The EMBO journal 37 (7), e98049, 2018	790	2018
Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease H Wesseling, W Mair, M Kumar, CN Schlaffner, S Tang, P Beerepoot, ... Cell 183 (6), 1699-1713. e13, 2020	406	2020
Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease B Eftekharzadeh, JG Daigle, LE Kapinos, A Coyne, J Schiantarelli, ... Neuron 99 (5), 925-940. e7, 2018	359	2018
Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo MA Busche, S Wegmann, S Dujardin, C Commins, J Schiantarelli, ... Nature neuroscience 22 (1), 57-64, 2019	341	2019
What is the evidence that tau pathology spreads through prion-like propagation? A Mudher, M Colin, S Dujardin, M Medina, I Dewachter, SM Alavi Naini, ... Acta neuropathologica communications 5, 1-20, 2017	331	2017
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease S Dujardin, C Commins, A Lathuiliere, P Beerepoot, AR Fernandes, ... Nature medicine 26 (8), 1256-1263, 2020	310	2020
Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies M Tardivel, S Bégard, L Bousset, S Dujardin, A Coens, R Melki, L Buée, ... Acta neuropathologica communications 4, 1-14, 2016	278	2016
Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies S Dujardin, K Lécolle, R Caillierez, S Bégard, N Zommer, C Lachaud, ... Acta neuropathologica communications 2, 1-14, 2014	259	2014
Ectosomes: a new mechanism for non-exosomal secretion of tau protein S Dujardin, S Bégard, R Caillierez, C Lachaud, L Delattre, S Carrier, ... PloS one 9 (6), e100760, 2014	247	2014
Enhanced tau aggregation in the presence of amyloid β RE Bennett, SL DeVos, S Dujardin, B Corjuc, R Gor, J Gonzalez, AD Roe, ... The American journal of pathology 187 (7), 1601-1612, 2017	214	2017
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia H Makishima, AM Jankowska, MA McDevitt, C O'Keefe, S Dujardin, ... Blood, The Journal of the American Society of Hematology 117 (21), e198-e206, 2011	185	2011
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy M Colin, S Dujardin, S Schraen-Maschke, G Meno-Tetang, C Duyckaerts, ... Acta neuropathologica 139 (1), 3-25, 2020	148	2020
Selection of an efficient AAV vector for robust CNS transgene expression KS Hanlon, JC Meltzer, T Buzhdygan, MJ Cheng, M Sena-Esteves, ... Molecular Therapy-Methods & Clinical Development 15, 320-332, 2019	114	2019
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo SL DeVos, BT Corjuc, C Commins, S Dujardin, RN Bannon, D Corjuc, ... Brain 141 (7), 2194-2212, 2018	93	2018
Different tau species lead to heterogeneous tau pathology propagation and misfolding S Dujardin, S Bégard, R Caillierez, C Lachaud, S Carrier, S Lieger, ... Acta neuropathologica communications 6, 1-12, 2018	92	2018
Invited review: animal models of tauopathies and their implications for research/translation into the clinic S Dujardin, M Colin, L Buée Neuropathology and applied neurobiology 41 (1), 59-80, 2015	88	2015
Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism JM Cooper, A Lathuiliere, M Migliorini, AL Arai, MM Wani, S Dujardin, ... Journal of Biological Chemistry 296, 2021	60	2021
Tau prion-like propagation: state of the art and current challenges S Dujardin, BT Hyman Tau Biology, 305-325, 2020	57	2020
In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy M Calvo-Rodriguez, SS Hou, AC Snyder, S Dujardin, H Shirani, ... Acta neuropathologica communications 7, 1-10, 2019	46	2019
Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain R Caillierez, S Bégard, K Lécolle, V Deramecourt, N Zommer, S Dujardin, ... Molecular Therapy 21 (7), 1358-1368, 2013	45	2013

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs